Mergers & Acquisitions

Future Farm Acquires 10-acres Operating Greenhouse in Florida Generating $2.8 Million in Revenue

Future Farm Acquires 10-acres Operating Greenhouse in Florida Generating $2.8 Million in Revenue PR Newswire VANCOUVER, British Columbia, January 5, 2018 VANCOUVER, British Columbia , January 5, 2018 /PRNewswire/ — Future Farm Technologies Inc. (the “Company” or “Future Farm”) ( CSE: FFT ) ( OTCQB: FFRMF ) is pleased to announce that it has closed on the previously announced 10-acre operating greenhouse acquisition, which generated approximately $2,800,000 USD in revenue and $400,000 USD in EBITDA for 2017*. The purchase price was $3,000,000 or 1.07X revenue. […]

Stock Analysts

Verizon (VZ) Inks Extended Carriage Deal With A+E Networks

Verizon Communications Inc VZ and A+E Networks have signed an extended carriage deal, which will broadcast A+E Networks programming in the company’s digital and mobile media platforms. The deal covers A+E cable networks which include A&E, History, Lifetime, Viceland and FYI. Verizon’s FiOS customers can access the network’s programming, comprising shows like Knightfall, Vikings and Live PD on their mobile devices. […]

Stock Analysts

Hyatt Place Hotel Opens in Frankfurt Airport, Expands in Europe

Hyatt Hotels Corporation H recently introduced the Hyatt Place brand in Germany with the launch of Hyatt Place Frankfurt Airport. The 312-roomed Hyatt Place Frankfurt Airport is the seventh Hyatt Place hotel in Europe, underscoring the growing demand for the brand in this part of the world. It is located in close proximity to the Frankfurt Airport and has efficient transport links with Frankfurt’s city center and the wider Rhine-Main region. […]

Stock Analysts

Beat the Market with Rising P/E Technique

Investors are well aware of low P/E investing and its positives. The common investor perception is that the lower the P/E, the higher will be the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (or is not equivalent to) its higher earnings and therefore has room to run […]

Stock Analysts

Infosys Teams Up With ValGenesis to Improve Digitization

Infosys Limited INFY recently announced a new collaboration with ValGenesis to bring a stronger compliance and quality management for its healthcare and life sciences sectors’ customers. The partnership will integrate ValGenesis’ Validation Lifecycle Management System (“VLMS”) within Infosys’ suite of services, facilitating delivery of services in a rapidly deployable and highly secure cloud environment. […]

Stock Analysts

Pharma Stock Roundup: Allergan Announces Job Cuts, Pfizer Inks Deals

The week has been pretty slow with key announcements including Allergan’s AGN job cut announcement and Pfizer’s PFE collaboration agreements with companies like Sangamo and Arvinas. Recap of the Week’s Most Important Stories Allergan Announces Job Cuts: At the time of announcing third quarter results in November, Allergan had said that it would have to look at cost reduction in order to deal with the impact of loss of exclusivity (“LOE”) on key products including Restasis. This week, the company announced a cost cutting and restructuring program which will lead to the elimination of more than 1,000 currently filled positions, primarily in commercial and other functions. […]

Momentum Stocks

Bull of the Day: Statoil (STO)

Commodity prices have been on the move in recent weeks. Part of that move can be attributed to a weakening US dollar but another big chunk of that is chalked up to increased global demand. With the world economy humming along on all cylinders, demand for energy is on the move […]

Mergers & Acquisitions

Takeda Announces Intention to Acquire TiGenix

Takeda Announces Intention to Acquire TiGenix PR Newswire OSAKA, Japan, January 5, 2018 OSAKA, Japan , January 5, 2018 /PRNewswire/ — Expands Takeda ‘ s Late Stage Pipeline and Leadership in Gastroenterology Acquisition Highlights Deal reinforces Takeda’s commitment to patients living with Inflammatory Bowel Disease (IBD), an area of high unmet medical need Acquisition extends existing collaboration between Takeda and TiGenix to develop and commercialize Cx601 (darvadstrocel) On December 15, 2017 , the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorization for Cx601 for the treatment of complex perianal fistulas in Crohn’s disease, one of the most disabling manifestations of the disease A global, pivotal Phase III trial for U.S. registration has been initiated with investigational medicine Cx601 for the treatment of complex perianal fistulas in patients with non-active/mildly active luminal Crohn’s disease Acquisition would expand Takeda’s late stage gastroenterology pipeline and strengthen presence in the U.S. specialty care market Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced its intention to acquire TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”), an advanced biopharmaceutical company developing novel stem cell therapies for serious medical conditions, and as a result has entered into an offer and support agreement with TiGenix which provides for a recommended potential voluntary public takeover bid for TiGenix. […]

Stock Analysts

3 Large-Cap Pharma Stocks to Watch Out for This New Year

The year 2017 has turned out to be pretty impressive for the pharma/biotech stocks. Though the industry was hampered by drug pricing issues in 2016, it bounced back and made a considerable headway in 2017, courtesy of a slew of FDA approvals. The regulatory body approved 46 novel drugs last year, easily surpassing 2016’s total tally of 22. […]